NeuroOne Medical reports FY24 EPS (46c) vs (65c) last year

Reports FY24 product revenue $3.453M vs $1.952M last year. “This year was highlighted by our expanded partnership with Zimmer Biomet-one of the world’s largest medical device manufacturers-whereby they will exclusively distribute our OneRF(TM) Ablation System for use in the brain throughout the United States and certain international markets,” says Dave Rosa, CEO of NeuroOne. “Following receipt of a $3 million upfront payment in November, we are now working closely with Zimmer’s team to complete training and prepare for their launch in the next few weeks. Going forward, we expect this partnership to increase revenues and expand margins significantly. To that end, we expect revenues to increase to at least $8 million in fiscal year 2025-representing a year-over-year increase of at least 132%-and gross margins to expand from 31% in fiscal year 2024 to at least 47% in fiscal year 2025.”